Michael Disciglio
Internal Medicine · Ocean, NJNPI 1922075373
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 403 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,733 and has fallen 90.9% since, to $250 in 2025. Among internal medicine clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 403 payments — averaging $16.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- GSK$564
- Amarin Pharma, Inc.$475
- Amgen$427
- AbbVie$415
- AstraZeneca$340
- plus $3K from 29 others
What the payments were for
- Speaking & faculty fees$110%
- Food & beverage$6,450100%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 91 | $1,305 |
| GSK | 18 | $564 |
| Amarin Pharma, Inc. | 26 | $475 |
| Amgen(2 entities) | 33 | $427 |
| AbbVie(2 entities) | 18 | $415 |
| AstraZeneca(2 entities) | 24 | $340 |
| Lilly USA, LLC | 26 | $333 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 24 | $326 |
| Pfizer | 20 | $285 |
| Merck | 22 | $283 |
| Gilead | 2 | $250 |
| Johnson & Johnson | 22 | $231 |
| Sanofi-aventis U.S. LLC | 12 | $161 |
| Biohaven Pharmaceuticals, Inc. | 3 | $152 |
| Radius Health, Inc. | 11 | $140 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $122 |
| Genentech USA, Inc. | 1 | $96 |
| Eisai Inc. | 6 | $83 |
| Kowa Pharmaceuticals America, Inc. | 6 | $77 |
| Boehringer Ingelheim | 5 | $70 |
| Mannkind Corporation | 5 | $65 |
| Currax Pharmaceuticals LLC | 3 | $41 |
| Teva Pharmaceuticals USA, Inc. | 3 | $38 |
| Astellas Pharma US Inc | 2 | $27 |
| Bayer | 1 | $22 |
| Tactile Systems Technology Inc | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $15 |
| Vivus LLC | 1 | $15 |
| Sanofi | 1 | $15 |
| BD | 1 | $15 |
| IBSA Pharma Inc. | 1 | $14 |
| Lundbeck LLC | 1 | $14 |
| Strongbridge US Inc. | 1 | $14 |
| Acorda Therapeutics, Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Vascepa$143
- ANORO$125
- Trodelvy$125
- TRELEGY ELLIPTA$121
- UBRELVY$121
- NURTEC ODT$119
- RYBELSUS$119
How this compares
$6,475 in reported general payments places this provider in the 90th percentile of 4,032 internal medicine providers in New Jersey.
Other internal medicine in Ocean
- David ShulkinMorristown$1.7M
- Howard UdermanLakewood$955K
- Darshi SunderamEast Orange$530K
- Annika DrongeEmerson$401K
- Stephen MarcellaNew Brunswick$331K
- Viju VijaysadanKinnelon$325K
- Mark MonaneWoodcliff Lake$268K
- Martin BedigianLivingston$240K
- Rameck HuntPlainsboro$217K
- Angel LazoSecaucus$195K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.